Dare Bioscience, Inc. — Director's Dealing 2016

Oct 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2016-10-25

Reporting Person: Eliasof Scott (SVP, Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-25	Employee Stock Option (right to buy)	$0.8754	A	10000	Acquired	2026-10-24	Common Stock (10000)	Direct

Footnotes

F1: This option was granted on October 25, 2016. The shares underlying the option are subject to vest in equal monthly installments over four years from the grant date.